推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

DRUG DISCOVERY TODAY

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 DRUG DISCOV TOD最新评论:您好,请问提交manuscript时,coverletter以文件的方式提交了,还需要再以邮件的方式给编辑发一遍吗? (2024-03-05)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


DRUG DISCOVERY TODAY期刊基本信息Hello,您是该期刊的第75099位访客


基本信息 登录收藏
期刊名字DRUG DISCOVERY TODAYDRUG DISCOVERY TODAY

DRUG DISCOV TODAY
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
8.0
53人评分
我要评分

声誉
8.8

影响力
7.2

速度
9.2

期刊ISSN1359-6446
微信扫码收藏此期刊
E-ISSN1878-5832
2023-2024最新影响因子
(数据来源于搜索引擎)
6.5 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:6.281
2023-2024自引率3.10%点击查看自引率趋势图
五年影响因子7.3
JCI期刊引文指标 1.05
h-index 157
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
14.801.5861.516
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q117 / 313
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Drug Discovery
Q19 / 157

期刊简介
Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed.

Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
Coverage includes:
• Novel therapeutic strategies
• High-throughput screening
• Therapeutic targets
• Combinatorial chemistry, parallel synthesis and library design
• Drug delivery
• ADME/Tox
• Advances in key compound classes and therapeutic areas
• Genomics and proteomics
• Automation and technology
• Virtual chemistry
• Informatics
• Business strategy
• Clinical trials
and other aspects of drug discovery.
期刊官方网站http://www.sciencedirect.com/science/journal/13596446
期刊投稿网址https://www.editorialmanager.com/DRUDIS
期刊语言要求Language
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足DRUG DISCOVERY TODAY的语言要求,还能让DRUG DISCOVERY TODAY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被DRUG DISCOVERY TODAY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB
出版商Elsevier Ltd
涉及的研究方向医学-药学
出版国家或地区ENGLAND
出版语言English
出版周期Semimonthly
出版年份1996
年文章数 239点击查看年文章数趋势图
Gold OA文章占比25.12%
研究类文章占比:
文章 ÷(文章 + 综述)
0.00%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ123/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ176/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
PHARMACOLOGY & PHARMACY
药学
1区1区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区2区1区
PHARMACOLOGY & PHARMACY
药学
1区4区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区2区1区
PHARMACOLOGY & PHARMACY
药学
1区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1359-6446%5BISSN%5D
平均审稿速度网友分享经验:
平均6.0个月
平均录用比例网友分享经验:
较难
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在DRUG DISCOVERY TODAY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 DRUG DISCOVERY TODAY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 DRUG DISCOVERY TODAY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
DRUG DISCOVERY TODAY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    PHARMACOLOGICAL REVIEWS21034.70
    DRUG RESISTANCE UPDATES10026.20
    ADVANCED DRUG DELIVERY REVIEWS27828.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.90
    PHARMACOLOGY & THERAPEUTICS18023.00
    MEDICINAL RESEARCH REVIEWS11929.30
    PHARMACOLOGICAL RESEARCH11818.70
    ARCHIVES OF PHARMACAL RESEARCH7513.40
    BIOMEDICINE & PHARMACOTHERAPY7811.90
    BRITISH JOURNAL OF PHARMACOLOGY19015.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE633162
    BIOMATERIALS537024
    BIOMEDICINE & PHARMACOTHERAPY501606
    Frontiers in Pharmacology479014
    Journal of Materials Chemistry B478057
    Frontiers in Immunology452830
    JOURNAL OF ETHNOPHARMACOLOGY431250
    COLLOIDS AND SURFACES B-BIOINTERFACES418953
    COMPUTERS IN BIOLOGY AND MEDICINE416640
    Frontiers in Oncology407456
  •  

    DRUG DISCOVERY TODAY DRUG DISCOVERY TODAY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Medicinal chemistry insights into antiviral peptidomimetics

    Author: Ding, Dang; Xu, Shujing; da Silva-Junior, Edeildo Ferreira; Liu, Xinyong; Zhan, Peng
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. 1-8. DOI: 10.1016/j.drudis.2022.103468
        PubMed      DOI
    2.Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

    Author: Lv, Yixin; Zhang, Zhoudong; Tian, Sheng; Wang, Weipeng; Li, Huanqiu
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 1, pp. -. DOI: 10.1016/j.drudis.2022.103394
        PubMed      DOI
    3.The transmembrane domains of GPCR dimers as targets for drug development

    Author: Cai, Xin; Wang, Dexiu; Zhang, Rumin; Chen, Yanchun; Chen, Jing
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 1, pp. -. DOI: 10.1016/j.drudis.2022.103419
        PubMed      DOI
    4.Cordycepin and kinase inhibition in cancer

    Author: Khan, Md Asaduzzaman; Tania, Mousumi
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103481
        PubMed      DOI
    5.Intra-articular nanodrug delivery strategies for treating osteoarthritis

    Author: Zhou, Dongyang; Zhou, Fengjin; Sheng, Shihao; Wei, Yan; Chen, Xiao; Su, Jiacan
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103482
        PubMed      DOI
    6.Engineered organic nanoparticles to combat biofilms

    Author: Sheng, Yuze; Chen, Zhongjian; Wu, Wei; Lu, Yi
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 2, pp. -. DOI: 10.1016/j.drudis.2022.103455
        PubMed      DOI
    7.Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis

    Author: Li, Haiyan; Guan, Ting; Qin, Shi; Xu, Qihao; Yin, Lina; Hu, Qingzhong
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103471
        PubMed      DOI
    8.Rapid progress in neuroimaging technologies fuels central nervous system translational medicine

    Author: Kong, Linghui; He, Qian; Li, Qiu; Schreiber, Rudy; Kaitin, Kenneth I.; Shao, Liming
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2023.103485
        PubMed      DOI
    9.Oral delivery of nucleic acid therapeutics: Challenges, strategies, and opportunities

    Author: Jiang, Xiaohe; Wang, Ning; Liu, Chang; Zhuo, Yan; Liang, Li; Gan, Yong; Yu, Miaorong
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 4, pp. -. DOI: 10.1016/j.drudis.2023.103507
        PubMed      DOI
    10.Recent advances in predicting lncRNA- disease associations based on computational methods

    Author: Yan, Jing; Wang, Ruobing; Tan, Jianjun
    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 2, pp. -. DOI: 10.1016/j.drudis.2022.103432
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity069.90
    Living Reviews in Relativity7569.90
    Advanced Composites and Hybrid Materials026.00
    Kidney International Supplements2026.70
    Kidney International Supplements2426.70
    Wiley Interdisciplinary Reviews-Computational Molecular Science6228.90
    Military Medical Research038.40
    NUCLEIC ACIDS RESEARCH45227.10
    Environmental Chemistry Letters5032.00
    Journal of the National Comprehensive Cancer Network8820.20
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共32


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室